{
    "title": "Novo Nordisk A/S. Q3 FY23 Income Statement",
    "subtitle": " Income Statement, for 3 months ended sep 30, 2023ï¼Œin DKK million",
    "unit": "M",
    "values": [
        {
            "id": "DiabetesCare",
            "v": 42574,
            "color": "blue",
            "name": "Diabetes care"
        },
        {
            "id": "Revenue",
            "v": 58731,
            "color": "blue",
            "name": "Revenue"
        },
        {
            "id": "CostOfRevenue",
            "v": 9713,
            "color": "blue",
            "name": "Cost of Revenue"
        },
        {
            "id": "Obesity",
            "v": 12255,
            "color": "blue",
            "name": "Obesity"
        },
        {
            "id": "GrossProfit",
            "v": 49018,
            "color": "blue",
            "name": "Gross Profit"
        },
        {
            "id": "OperatingExpense",
            "v": 22105,
            "color": "blue",
            "name": "Operating Expense"
        },
        {
            "id": "R&D",
            "v": 8128,
            "color": "blue",
            "name": "R&D"
        },
        {
            "id": "RareDisease",
            "v": 3902,
            "color": "blue",
            "name": "Rare disease"
        },
        {
            "id": "SalesAndDistribution",
            "v": 12819,
            "color": "blue",
            "name": "Sales and Distribution"
        },
        {
            "id": "Admin",
            "v": 1256,
            "color": "blue",
            "name": "Admin"
        },
        {
            "id": "OtherOperatingIncome",
            "v": 98,
            "color": "blue",
            "name": "Other Operating income"
        },
        {
            "id": "OperatingProfit",
            "v": 26913,
            "color": "blue",
            "name": "Operating Profit"
        },
        {
            "id": "FinancialIncome",
            "v": 1150,
            "color": "blue",
            "name": "Financial Income"
        },
        {
            "id": "Tax",
            "v": 5585,
            "color": "blue",
            "name": "Tax"
        },
        {
            "id": "NetIncome",
            "v": 22478,
            "color": "blue",
            "name": "Net Income"
        }
    ],
    "link": [
        {
            "from": "DiabetesCare",
            "to": "Revenue"
        },
        {
            "from": "Obesity",
            "to": "Revenue"
        },
        {
            "from": "RareDisease",
            "to": "Revenue"
        },
        {
            "from": "Revenue",
            "to": "CostOfRevenue"
        },
        {
            "from": "Revenue",
            "to": "GrossProfit"
        },
        {
            "from": "GrossProfit",
            "to": "OperatingExpense"
        },
        {
            "from": "OperatingExpense",
            "to": "R&D"
        },
        {
            "from": "OperatingExpense",
            "to": "SalesAndDistribution"
        },
        {
            "from": "OperatingExpense",
            "to": "Admin"
        },
        {
            "from": "OperatingProfit",
            "to": "Tax"
        },
        {
            "from": "OperatingProfit",
            "to": "NetIncome"
        },
        {
            "from": "FinancialIncome",
            "to": "NetIncome"
        }
    ]
}